home / stock / zyme / zyme articles

ZYME Articles, Zymeworks Inc. - From 05/20/24

Stock Information
Company Name: Zymeworks Inc.
Stock Symbol: ZYME
Market: NYSE
Website: zymeworks.com
Menu
ZYME ZYME Quote ZYME Short ZYME News ZYME Articles ZYME Message Board
Get ZYME Alerts

News, Short Squeeze, Breakout and More Instantly...
Bragar Eagel & Squire, P.C. Is Investigating Zymeworks, Regeneron, Jabil, and DoubleVerify and Encourages Investors to Contact the Firm | Benzinga

NEW YORK, May 19, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigatin...
Zymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024 | Benzinga

VANCOUVER, British Columbia, April 11, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (NASDAQ:ZYME), a clinical-stage biotechnology company developing ...

Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting | Benzinga

VANCOUVER, British Columbia, April 08, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (NASDAQ:ZYME), a clinical-stage biotechnology company developing ...

ZYMEWORKS ALERT: Bragar Eagel & Squire, P.C. is Investigating Zymeworks Inc. on Behalf of Zymeworks Stockholders and Encourages Investors to Contact the Firm | Benzinga

NEW YORK, April 03, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigat...
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Zymeworks Inc. (ZYME) | Benzinga

NEW YORK, April 02, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Zymeworks Inc. ("Zyme...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYME | Benzinga

NEW YORK, April 01, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Zymeworks Inc. ("Zymeworks" or the ...

Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors | Benzinga

VANCOUVER, British Columbia, March 28, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (NASDAQ:ZYME), a clinical-stage biotechnology company developing ...
Zymeworks Announces Appointment of Dr. Alessandra Cesano to its Board of Directors | Benzinga

VANCOUVER, British Columbia, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (NASDAQ:ZYME), a clinical-stage biotechnology company developing a...

Overview Of Value Stocks In The Healthcare Sector | Benzinga

What is a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicate...

Zymeworks Outlines Strategic Priorities and Outlook for 2024 and 2025 | Benzinga

Company well-positioned for further progress and broadening of R&D pipeline Cash resources of approximately $455 million as of December 31, 2...
Previous 10 Next 10